4,6-dimethyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-oxo-1H-pyridine-3-carboxamide;1-(2-ethyl-5-methylpyrimidin-4-yl)-2-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]ethanone;2-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-piperidin-4-ylethanone;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-7H-pyrrolo[1,2-a]imidazole-2-carboxamide

C91H102N28O9 — CID 160501112

IUPAC4,6-dimethyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-oxo-1H-pyridine-3-carboxamide;1-(2-ethyl-5-methylpyrimidin-4-yl)-2-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]ethanone;2-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-piperidin-4-ylethanone;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-7H-pyrrolo[1,2-a]imidazole-2-carboxamide
SMILESCCc1ncc(C)c(C(=O)Cc2cn[nH]c2-c2nc3ccc(CN4CCOCC4)cc3[nH]2)n1.Cc1cc(C)c(C(=O)Nc2cn[nH]c2-c2nc3ccc(CN4CCOCC4)cc3[nH]2)c(=O)[nH]1.O=C(Cc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)C1CCNCC1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1cn2c(n1)CC=C2
InChIInChI=1S/C24H27N7O2.C23H25N7O3.C22H22N8O2.C22H28N6O2/c1-3-21-25-12-15(2)22(29-21)20(32)11-17-13-26-30-23(17)24-27-18-5-4-16(10-19(18)28-24)14-31-6-8-33-9-7-31;1-13-9-14(2)25-22(31)19(13)23(32)28-18-11-24-29-20(18)21-26-16-4-3-15(10-17(16)27-21)12-30-5-7-33-8-6-30;31-22(18-13-30-5-1-2-19(30)24-18)27-17-11-23-28-20(17)21-25-15-4-3-14(10-16(15)26-21)12-29-6-8-32-9-7-29;29-20(16-3-5-23-6-4-16)12-17-13-24-27-21(17)22-25-18-2-1-15(11-19(18)26-22)14-28-7-9-30-10-8-28/h4-5,10,12-13H,3,6-9,11,14H2,1-2H3,(H,26,30)(H,27,28);3-4,9-11H,5-8,12H2,1-2H3,(H,24,29)(H,25,31)(H,26,27)(H,28,32);1,3-5,10-11,13H,2,6-9,12H2,(H,23,28)(H,25,26)(H,27,31);1-2,11,13,16,23H,3-10,12,14H2,(H,24,27)(H,25,26)
InChIKeyQRUFYWPEJGCANH-UHFFFAOYSA-N
MW1732.00 g/mol
LogP9.37
Rot. Bonds23

About 4,6-dimethyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-oxo-1H-pyridine-3-carboxamide;1-(2-ethyl-5-methylpyrimidin-4-yl)-2-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]ethanone;2-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-piperidin-4-ylethanone;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-7H-pyrrolo[1,2-a]imidazole-2-carboxamide

4,6-dimethyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-oxo-1H-pyridine-3-carboxamide;1-(2-ethyl-5-methylpyrimidin-4-yl)-2-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]ethanone;2-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-piperidin-4-ylethanone;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-7H-pyrrolo[1,2-a]imidazole-2-carboxamide (PubChem CID 160501112) has the molecular formula C91H102N28O9 and a molecular weight of 1732.00 g/mol. Its IUPAC name is 4,6-dimethyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-oxo-1H-pyridine-3-carboxamide;1-(2-ethyl-5-methylpyrimidin-4-yl)-2-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]ethanone;2-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-piperidin-4-ylethanone;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-7H-pyrrolo[1,2-a]imidazole-2-carboxamide.

Molecular Properties

Compound Name4,6-dimethyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-oxo-1H-pyridine-3-carboxamide;1-(2-ethyl-5-methylpyrimidin-4-yl)-2-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]ethanone;2-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-piperidin-4-ylethanone;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-7H-pyrrolo[1,2-a]imidazole-2-carboxamide
PubChem CID160501112
Molecular FormulaC91H102N28O9
Molecular Weight1732.00 g/mol
Exact Mass1730.84
IUPAC Name4,6-dimethyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-oxo-1H-pyridine-3-carboxamide;1-(2-ethyl-5-methylpyrimidin-4-yl)-2-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]ethanone;2-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-piperidin-4-ylethanone;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-7H-pyrrolo[1,2-a]imidazole-2-carboxamide
SMILESCCc1ncc(C)c(C(=O)Cc2cn[nH]c2-c2nc3ccc(CN4CCOCC4)cc3[nH]2)n1.Cc1cc(C)c(C(=O)Nc2cn[nH]c2-c2nc3ccc(CN4CCOCC4)cc3[nH]2)c(=O)[nH]1.O=C(Cc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)C1CCNCC1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1cn2c(n1)CC=C2
InChIInChI=1S/C24H27N7O2.C23H25N7O3.C22H22N8O2.C22H28N6O2/c1-3-21-25-12-15(2)22(29-21)20(32)11-17-13-26-30-23(17)24-27-18-5-4-16(10-19(18)28-24)14-31-6-8-33-9-7-31;1-13-9-14(2)25-22(31)19(13)23(32)28-18-11-24-29-20(18)21-26-16-4-3-15(10-17(16)27-21)12-30-5-7-33-8-6-30;31-22(18-13-30-5-1-2-19(30)24-18)27-17-11-23-28-20(17)21-25-15-4-3-14(10-16(15)26-21)12-29-6-8-32-9-7-29;29-20(16-3-5-23-6-4-16)12-17-13-24-27-21(17)22-25-18-2-1-15(11-19(18)26-22)14-28-7-9-30-10-8-28/h4-5,10,12-13H,3,6-9,11,14H2,1-2H3,(H,26,30)(H,27,28);3-4,9-11H,5-8,12H2,1-2H3,(H,24,29)(H,25,31)(H,26,27)(H,28,32);1,3-5,10-11,13H,2,6-9,12H2,(H,23,28)(H,25,26)(H,27,31);1-2,11,13,16,23H,3-10,12,14H2,(H,24,27)(H,25,26)
InChIKeyQRUFYWPEJGCANH-UHFFFAOYSA-N
XLogP9.37
TPSA460.15 Ų
H-Bond Donors12
H-Bond Acceptors26
Rotatable Bonds23
Heavy Atoms128
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001732.00
LogP ≤ 59.37
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1026

Analyze 4,6-dimethyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-oxo-1H-pyridine-3-carboxamide;1-(2-ethyl-5-methylpyrimidin-4-yl)-2-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]ethanone;2-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-piperidin-4-ylethanone;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-7H-pyrrolo[1,2-a]imidazole-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4,6-dimethyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-oxo-1H-pyridine-3-carboxamide;1-(2-ethyl-5-methylpyrimidin-4-yl)-2-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]ethanone;2-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-piperidin-4-ylethanone;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-7H-pyrrolo[1,2-a]imidazole-2-carboxamide?
The IUPAC name of 4,6-dimethyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-oxo-1H-pyridine-3-carboxamide;1-(2-ethyl-5-methylpyrimidin-4-yl)-2-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]ethanone;2-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-piperidin-4-ylethanone;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-7H-pyrrolo[1,2-a]imidazole-2-carboxamide (CID 160501112) is 4,6-dimethyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-oxo-1H-pyridine-3-carboxamide;1-(2-ethyl-5-methylpyrimidin-4-yl)-2-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]ethanone;2-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-piperidin-4-ylethanone;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-7H-pyrrolo[1,2-a]imidazole-2-carboxamide.
What is the SMILES notation for 4,6-dimethyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-oxo-1H-pyridine-3-carboxamide;1-(2-ethyl-5-methylpyrimidin-4-yl)-2-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]ethanone;2-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-piperidin-4-ylethanone;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-7H-pyrrolo[1,2-a]imidazole-2-carboxamide?
The canonical SMILES for 4,6-dimethyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-oxo-1H-pyridine-3-carboxamide;1-(2-ethyl-5-methylpyrimidin-4-yl)-2-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]ethanone;2-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-piperidin-4-ylethanone;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-7H-pyrrolo[1,2-a]imidazole-2-carboxamide is CCc1ncc(C)c(C(=O)Cc2cn[nH]c2-c2nc3ccc(CN4CCOCC4)cc3[nH]2)n1.Cc1cc(C)c(C(=O)Nc2cn[nH]c2-c2nc3ccc(CN4CCOCC4)cc3[nH]2)c(=O)[nH]1.O=C(Cc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)C1CCNCC1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1cn2c(n1)CC=C2.
What is the InChIKey of 4,6-dimethyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-oxo-1H-pyridine-3-carboxamide;1-(2-ethyl-5-methylpyrimidin-4-yl)-2-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]ethanone;2-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-piperidin-4-ylethanone;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-7H-pyrrolo[1,2-a]imidazole-2-carboxamide?
The InChIKey is QRUFYWPEJGCANH-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H27N7O2.C23H25N7O3.C22H22N8O2.C22H28N6O2/c1-3-21-25-12-15(2)22(29-21)20(32)11-17-13-26-30-23(17)24-27-18-5-4-16(10-19(18)28-24)14-31-6-8-33-9-7-31;1-13-9-14(2)25-22(31)19(13)23(32)28-18-11-24-29-20(18)21-26-16-4-3-15(10-17(16)27-21)12-30-5-7-33-8-6-30;31-22(18-13-30-5-1-2-19(30)24-18)27-17-11-23-28-20(17)21-25-15-4-3-14(10-16(15)26-21)12-29-6-8-32-9-7-29;29-20(16-3-5-23-6-4-16)12-17-13-24-27-21(17)22-25-18-2-1-15(11-19(18)26-22)14-28-7-9-30-10-8-28/h4-5,10,12-13H,3,6-9,11,14H2,1-2H3,(H,26,30)(H,27,28);3-4,9-11H,5-8,12H2,1-2H3,(H,24,29)(H,25,31)(H,26,27)(H,28,32);1,3-5,10-11,13H,2,6-9,12H2,(H,23,28)(H,25,26)(H,27,31);1-2,11,13,16,23H,3-10,12,14H2,(H,24,27)(H,25,26).
What are the key properties of 4,6-dimethyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-oxo-1H-pyridine-3-carboxamide;1-(2-ethyl-5-methylpyrimidin-4-yl)-2-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]ethanone;2-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-piperidin-4-ylethanone;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-7H-pyrrolo[1,2-a]imidazole-2-carboxamide?
4,6-dimethyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-oxo-1H-pyridine-3-carboxamide;1-(2-ethyl-5-methylpyrimidin-4-yl)-2-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]ethanone;2-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-piperidin-4-ylethanone;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-7H-pyrrolo[1,2-a]imidazole-2-carboxamide has a molecular weight of 1732.00 g/mol, XLogP of 9.37, 23 rotatable bonds, 12 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for 4,6-dimethyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-oxo-1H-pyridine-3-carboxamide;1-(2-ethyl-5-methylpyrimidin-4-yl)-2-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]ethanone;2-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-piperidin-4-ylethanone;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-7H-pyrrolo[1,2-a]imidazole-2-carboxamide is sourced from PubChem (CID 160501112), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).